These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 8830016

  • 41. Cross-resistance between some aminoglycoside antibiotics.
    Onaolapo JA.
    Afr J Med Med Sci; 1994 Sep; 23(3):215-9. PubMed ID: 7604744
    [Abstract] [Full Text] [Related]

  • 42. Treatment of neutropenic infection: a randomized trial comparing latamoxef (moxalactam) with cephradine plus tobramycin.
    Bezwoda WR, Derman DP, Perkins S, Cassel R.
    J Antimicrob Chemother; 1985 Feb; 15(2):239-45. PubMed ID: 3884566
    [Abstract] [Full Text] [Related]

  • 43. Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials.
    Spoering AL, Lewis K.
    J Bacteriol; 2001 Dec; 183(23):6746-51. PubMed ID: 11698361
    [Abstract] [Full Text] [Related]

  • 44. In vivo Host Environment Alters Pseudomonas aeruginosa Susceptibility to Aminoglycoside Antibiotics.
    Pan X, Dong Y, Fan Z, Liu C, Xia B, Shi J, Bai F, Jin Y, Cheng Z, Jin S, Wu W.
    Front Cell Infect Microbiol; 2017 Dec; 7():83. PubMed ID: 28352614
    [Abstract] [Full Text] [Related]

  • 45. Synergism and postantibiotic effect of tobramycin and Melaleuca alternifolia (tea tree) oil against Staphylococcus aureus and Escherichia coli.
    D'Arrigo M, Ginestra G, Mandalari G, Furneri PM, Bisignano G.
    Phytomedicine; 2010 Apr; 17(5):317-22. PubMed ID: 19699074
    [Abstract] [Full Text] [Related]

  • 46. Bactericidal effect of combinations of cephalosporins with tobramycin on clinical isolates of Escherichia coli, Klebsiella and Staphylococcus aureus.
    Wagenvoort JH, Brus-Weijer L, Michel MF.
    Arzneimittelforschung; 1986 Sep; 36(9):1301-2. PubMed ID: 3539124
    [Abstract] [Full Text] [Related]

  • 47. Tobramycin, amikacin, sissomicin, and gentamicin resistant Gram-negative rods.
    Drasar FA, Farrell W, Maskell J, Williams JD.
    Br Med J; 1976 Nov 27; 2(6047):1284-7. PubMed ID: 1000196
    [Abstract] [Full Text] [Related]

  • 48. Two mechanisms of killing of Pseudomonas aeruginosa by tobramycin assessed at multiple inocula via mechanism-based modeling.
    Bulitta JB, Ly NS, Landersdorfer CB, Wanigaratne NA, Velkov T, Yadav R, Oliver A, Martin L, Shin BS, Forrest A, Tsuji BT.
    Antimicrob Agents Chemother; 2015 Apr 27; 59(4):2315-27. PubMed ID: 25645838
    [Abstract] [Full Text] [Related]

  • 49. R plasmids coding for gentamicin, tobramycin, and carbenicillin resistance in Serratia, Klebsiella and Escherichia coli strains from a single clinical source.
    Knothe H, Kettner M, Kopsová D, Krcméry V.
    Chemotherapy; 1977 Apr 27; 23(1):37-43. PubMed ID: 401718
    [Abstract] [Full Text] [Related]

  • 50. An Antipersister Strategy for Treatment of Chronic Pseudomonas aeruginosa Infections.
    Koeva M, Gutu AD, Hebert W, Wager JD, Yonker LM, O'Toole GA, Ausubel FM, Moskowitz SM, Joseph-McCarthy D.
    Antimicrob Agents Chemother; 2017 Dec 27; 61(12):. PubMed ID: 28923873
    [Abstract] [Full Text] [Related]

  • 51. Asiatic acid and corosolic acid enhance the susceptibility of Pseudomonas aeruginosa biofilms to tobramycin.
    Garo E, Eldridge GR, Goering MG, DeLancey Pulcini E, Hamilton MA, Costerton JW, James GA.
    Antimicrob Agents Chemother; 2007 May 27; 51(5):1813-7. PubMed ID: 17353241
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
    Shahid M, Malik A, Akram M, Agrawal LM, Khan AU, Agrawal M.
    Int J Infect Dis; 2008 May 27; 12(3):256-64. PubMed ID: 17981482
    [Abstract] [Full Text] [Related]

  • 54. Specific and non-specific resistance to aminoglycosides in Escherichia coli.
    Mawer SL, Greenwood D.
    J Clin Pathol; 1978 Jan 27; 31(1):12-5. PubMed ID: 342544
    [Abstract] [Full Text] [Related]

  • 55. In Vitro Antimicrobial Efficacy of Tobramycin Against Staphylococcus aureus Biofilms in Combination With or Without DNase I and/or Dispersin B: A Preliminary Investigation.
    Waryah CB, Wells K, Ulluwishewa D, Chen-Tan N, Gogoi-Tiwari J, Ravensdale J, Costantino P, Gökçen A, Vilcinskas A, Wiesner J, Mukkur T.
    Microb Drug Resist; 2017 Apr 27; 23(3):384-390. PubMed ID: 27754780
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Beta-lactam enhancement of aminoglycoside activity under conditions of reduced pH and oxygen tension that may exist in infected tissues.
    Bryant RE, Fox K, Oh G, Morthland VH.
    J Infect Dis; 1992 Apr 27; 165(4):676-82. PubMed ID: 1552196
    [Abstract] [Full Text] [Related]

  • 59. Potentiation of Tobramycin by Silver Nanoparticles against Pseudomonas aeruginosa Biofilms.
    Habash MB, Goodyear MC, Park AJ, Surette MD, Vis EC, Harris RJ, Khursigara CM.
    Antimicrob Agents Chemother; 2017 Nov 27; 61(11):. PubMed ID: 28848007
    [Abstract] [Full Text] [Related]

  • 60. Tobramycin resistance of mucoid Pseudomonas aeruginosa biofilm grown under iron limitation.
    Anwar H, Dasgupta M, Lam K, Costerton JW.
    J Antimicrob Chemother; 1989 Nov 27; 24(5):647-55. PubMed ID: 2513307
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.